Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses

Preferable treatments for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with brain metastasis are elusive. The study intended to estimate the relative efficacy and safety of systemic therapies. Clinical trials about therapies for EGFR-mutant, brain-metastatic NSCL...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Aging (Albany NY)
Auteurs principaux: Zhao, Binghao, Wang, Yuekun, Wang, Yaning, Chen, Wenlin, Zhou, Lizhou, Liu, Peng Hao, Kong, Ziren, Dai, Congxin, Wang, Yu, Ma, Wenbin
Format: Artigo
Langue:Inglês
Publié: Impact Journals 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425486/
https://ncbi.nlm.nih.gov/pubmed/32669477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103455
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires